“…Addictive states have thus been centrally conceptualized as “decision‐making diseases”: The joint influence of increased substance‐related reactivity (i.e., limbic overactivation, manifested by craving and attentional biases) and reduced executive control (i.e., prefrontal underactivation, leading to reduced inhibition abilities) drives patients to promote drug‐related choices, leading to addiction persistence (Wiers and Stacy, ). While this classical dual‐process view (Stacy and Wiers, ) is currently challenged (Hommel and Wiers, ; Melnikoff and Bargh, ), the most influential neurocognitive models of addictions still consider altered decision making as a key theoretical and clinical factor (e.g., Koob and Volkow, ; Volkow and Baler, ; Wise and Koob, ).…”